ADCT
ADC Therapeutics SA
1.30$
+6.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -4,156.7% | -10,645.8% | -5,195.8% | – | -688.1% | -65.2% | -170.6% | -174.8% | -173.5% | |
| 18.9% | 64.9% | 70.3% | – | 7.8% | 1.1% | 4.7% | 4.6% | 2.3% | |
| 54.4% | 41.1% | 47.7% | – | 178.3% | 23.5% | 19.4% | 9.3% | 8.5% | |
| 59.0% | -17.4% | 40.6% | – | 42.2% | 23.7% | – | – | – | |
| 749.4% | 42.2% | -336.9% | – | -46.3% | -15.7% | 63.6% | 5.4% | -31.2% | |
| 175.0% | 216.7% | 91.8% | – | 18.8% | 0.3% | 4.6% | 1.2% | 0.3% | |
| -180.1% | -219.8% | -96.1% | – | -19.7% | -1.2% | -4.6% | -1.2% | 0.5% | |
| 10,939.5% | -2.1% | -6.0% | – | 0.0% | -0.1% | – | – | – | |
| -55.6% | -87.9% | -42.8% | – | 143.3% | -3.1% | 0.0% | – | – | |
| 10,939.5% | -2.1% | 4,295.4% | – | 788.4% | -0.3% | 106.2% | 137.0% | 185.5% | |
| 6,604.7% | -10,872.4% | -993.8% | – | 80.6% | -66.6% | -68.8% | -39.1% | 12.9% | |
| -4,331.7% | -10,862.5% | -5,287.6% | – | -706.9% | -65.4% | -175.3% | -176.0% | -173.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.